Sub-Nucleocapsid Nanoparticles: A Nasal Vaccine against Respiratory Syncytial Virus
Xavier Roux, Catherine Dubuquoy, Guillaume Durand et al. · 2008
Read Sub-Nucleocapsid Nanoparticles: A Nasal Vaccine against Respiratory Syncytial Virus by Xavier Roux, Catherine Dubuquoy, Guillaume Durand et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0001766.txt.
Description
Xavier Roux, Catherine Dubuquoy, Guillaume Durand, and their co-authors built a nasal vaccine candidate against a baby-threatening virus in a 2008 PLOS ONE research article. Respiratory syncytial virus causes bronchiolitis in children under two and is a growing public health concern. No safe, effective vaccine existed. The virus's nucleoprotein, a core component, had performed poorly as a vaccine part on its own.
The team packaged the nucleoprotein into sub-nucleocapsid nanoparticles and delivered them through the nose. The full text gives the particle design and the immune results. Nasal delivery suits a virus that enters through airways, and particle packaging can turn a weak antigen into a workable vaccine.
Catalog record
| CREATOR | Xavier Roux, Catherine Dubuquoy, Guillaume Durand et al. |
|---|---|
| YEAR | 2008 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 66 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0001766